Atara Biotherapeutics’ $175 Million Common Stock and Pre-Funded Warrants Offering

Cooley acted as counsel to Atara Biotherapeutics, Inc., while Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now